MA55710A - Procédé de production de dérivés de 2-[2-(phényl)éthylamino]alcaneamide substitués - Google Patents

Procédé de production de dérivés de 2-[2-(phényl)éthylamino]alcaneamide substitués

Info

Publication number
MA55710A
MA55710A MA055710A MA55710A MA55710A MA 55710 A MA55710 A MA 55710A MA 055710 A MA055710 A MA 055710A MA 55710 A MA55710 A MA 55710A MA 55710 A MA55710 A MA 55710A
Authority
MA
Morocco
Prior art keywords
alcaneamide
ethylamino
phenyl
derivatives
substituted
Prior art date
Application number
MA055710A
Other languages
English (en)
Inventor
Christoph Imboden
Matthias Riepl
Wolfgang Skranc
Erwin Waldvogel
Michael Wolberg
Original Assignee
Newron Pharm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newron Pharm Spa filed Critical Newron Pharm Spa
Publication of MA55710A publication Critical patent/MA55710A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/08Preparation of carboxylic acid nitriles by addition of hydrogen cyanide or salts thereof to unsaturated compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/36Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by hydroxy groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
MA055710A 2019-04-17 2020-04-08 Procédé de production de dérivés de 2-[2-(phényl)éthylamino]alcaneamide substitués MA55710A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP19169714.3A EP3725768A1 (fr) 2019-04-17 2019-04-17 Procédé de production de dérivés de 2-[2-(phényl)éthylamino]alkanéamide

Publications (1)

Publication Number Publication Date
MA55710A true MA55710A (fr) 2022-02-23

Family

ID=66217869

Family Applications (1)

Application Number Title Priority Date Filing Date
MA055710A MA55710A (fr) 2019-04-17 2020-04-08 Procédé de production de dérivés de 2-[2-(phényl)éthylamino]alcaneamide substitués

Country Status (15)

Country Link
US (1) US20220177417A1 (fr)
EP (2) EP3725768A1 (fr)
JP (1) JP2022529916A (fr)
KR (1) KR20210154206A (fr)
CN (1) CN113784944A (fr)
AR (1) AR118674A1 (fr)
AU (1) AU2020259726A1 (fr)
BR (1) BR112021020599A2 (fr)
CA (1) CA3136845A1 (fr)
IL (1) IL287228A (fr)
MA (1) MA55710A (fr)
MX (1) MX2021012713A (fr)
SG (1) SG11202111378SA (fr)
TW (1) TW202104164A (fr)
WO (1) WO2020212227A1 (fr)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127559D0 (en) * 2001-11-16 2002-01-09 Syngenta Participations Ag Organic compounds
PL377480A1 (pl) * 2002-12-10 2006-02-06 Pfizer Inc. Pochodne morfoliny do stosowania jako agoniści dopaminy w leczeniu między innymi dysfunkcji seksualnej
EP1685102A4 (fr) * 2003-11-12 2008-08-20 Lg Life Sciences Ltd Agonistes du recepteur de la melanocortine
CN101309909B (zh) * 2005-12-22 2012-11-14 纽朗制药有限公司 作为钙和/或钠通道调节剂的2-苯基乙基氨基衍生物
JP5260062B2 (ja) * 2006-01-20 2013-08-14 株式会社カネカ β−アミノ−α−ヒドロキシ酸アミド誘導体の製造法
JP5440496B2 (ja) 2007-06-15 2014-03-12 ニユーロン・フアーマシユーテイカルズ・エツセ・ピー・アー 置換2−[2−(フェニル)エチルアミノ]アルカンアミド誘導体ならびにナトリウムおよび/またはカルシウムチャネル調節剤としてのこれらの使用
EA030250B1 (ru) * 2007-12-11 2018-07-31 Ньюрон Фармасьютикалс С.П.А. Применение 2-[4-(3- или 2-фторбензилокси)бензиламино]пропанамидов с высокой степенью чистоты и содержащие их фармацевтические композиции
WO2013000651A1 (fr) 2011-06-27 2013-01-03 Newron Pharmaceuticals S.P.A. Dérivés d'arylalkylaminocarboxamides fluorés
JP2016523941A (ja) * 2013-07-09 2016-08-12 バイエル ファーマ アクチエンゲゼルシャフト 改変されたbetタンパク質阻害性ジヒドロキノキサリノンおよびジヒドロピリドピラジノン
CN105801437A (zh) * 2016-03-31 2016-07-27 常州大学 一种(甲基氨基)(苯基)甲醇的合成方法
CN114249668A (zh) * 2020-09-25 2022-03-29 鲁南制药集团股份有限公司 一种唑吡坦中间体n,n-二甲基-2-氧乙酰胺的制备方法

Also Published As

Publication number Publication date
IL287228A (en) 2021-12-01
EP3725768A1 (fr) 2020-10-21
JP2022529916A (ja) 2022-06-27
WO2020212227A1 (fr) 2020-10-22
AU2020259726A1 (en) 2021-12-09
SG11202111378SA (en) 2021-11-29
CN113784944A (zh) 2021-12-10
KR20210154206A (ko) 2021-12-20
EP3956295A1 (fr) 2022-02-23
BR112021020599A2 (pt) 2021-12-07
US20220177417A1 (en) 2022-06-09
MX2021012713A (es) 2021-11-12
AR118674A1 (es) 2021-10-20
CA3136845A1 (fr) 2020-10-22
TW202104164A (zh) 2021-02-01

Similar Documents

Publication Publication Date Title
MA51878A (fr) Composés d'aminothiazole en tant qu'inhibiteurs de c-kit
MA54253A (fr) Procédé de préparation de dérivés de 2-chloro-4-hétéroaryl-pyridimidines
MA53219A (fr) Nouveaux composés hétérocycliques en tant qu'inhibiteurs de monoacylglycérol lipase
MA52942A (fr) Composés inhibiteurs d'oga
MA52939A (fr) Composés inhibiteurs d'oga
DK3497081T3 (da) Fremgangsmåde til fremstilling af 4-ammonium-2,2,6,6-tetraalkylpiperidinylsalte
MA54521A (fr) Dérivés d'oxopyridine substitués
DK3692039T3 (da) Enantiomerer af substituerede thiazoler som antivirale forbindelser
MA56043A (fr) Dérivés hétérocycliques fusionnés
MA54396A (fr) Procédé de préparation de n-phénylpyrazole-1-carboxamides
MA50169A (fr) Procédé de production d'un électrocatalyseur
MA49700A (fr) Procédé amélioré pour la préparation de dérivés d'aminopyrimidine
DK3373931T3 (da) Heterocykliske forbindelser til behandling af sygdom
MA46859A (fr) Dérivés d'indole utiles en tant qu'inhibiteurs de la diacylglycéride o-acyltransférase 2
DK3818047T3 (da) Hidtil ukendte forbindelser til bekæmpelse af arthropoder
DK3737678T3 (da) Fremgangsmåde til fremstilling af disubstituerede diaryloxybenzoheterodiazolforbindelser
DK3820849T3 (da) Phenyl/pyridyl-nh-phenyl/pyridyl-derivater til behandling af rna-virusinfektion
MA50439A (fr) Nouveaux dérivés de pyrazolo-pyrrolo-pyrimidine-dione utilisés en tant qu'inhibiteurs de p2x3
MA55127A (fr) Procédé de production d'alcanones plus élevées, de préférence 6-undécanones, et leurs dérivés
MA55714A (fr) Procédé de production de dérivés de 2-[2-(phényl) éthylamino]alcaneamide substitués
MA55710A (fr) Procédé de production de dérivés de 2-[2-(phényl)éthylamino]alcaneamide substitués
MA51339A (fr) Procédé de préparation de composés pyrimidinyl-4-aminopyrazole
MA52934A (fr) Composés inhibiteurs de l'oga
MA52937A (fr) Composés inhibiteurs d'oga
MA52936A (fr) Composés inhibiteurs d'oga